Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma is a paper indexed in PICO Portal from OpenAlex.
How many citations does Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma have?
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma has 1,119 citations in the OpenAlex counts PICO Portal stores.
When was Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma published?
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma has 2019 year in the PICO Portal index.
What is the open-access status of Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma?
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma has hybrid oa status in the PICO Portal index.
What is the DOI of Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma?
The DOI for Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma is on the source record.
What is the PMID of Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma?
The PMID for Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma is on the source record.
What is the OpenAlex record for Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma?
The OpenAlex for Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma is on the source record.